Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10844340
[patent_doc_number] => 08871515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/561966
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25294
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12561966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561966 | Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof | Sep 16, 2009 | Issued |
Array
(
[id] => 7511672
[patent_doc_number] => 20110257382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Nucleic acid separation using immobilized metal affinity chromatography'
[patent_app_type] => utility
[patent_app_number] => 12/584889
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20892
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257382.pdf
[firstpage_image] =>[orig_patent_app_number] => 12584889
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/584889 | Nucleic acid separation using immobilized metal affinity chromatography | Sep 13, 2009 | Abandoned |
Array
(
[id] => 7499632
[patent_doc_number] => 20110262526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 12/737984
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 5374
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12737984
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/737984 | METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE | Sep 7, 2009 | Abandoned |
Array
(
[id] => 6536984
[patent_doc_number] => 20100015687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Tetracycline Repressor Regulated Oncolytic Viruses'
[patent_app_type] => utility
[patent_app_number] => 12/553051
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6117
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015687.pdf
[firstpage_image] =>[orig_patent_app_number] => 12553051
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553051 | Tetracycline repressor regulated oncolytic viruses | Sep 1, 2009 | Issued |
Array
(
[id] => 5464985
[patent_doc_number] => 20090325185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Method of analyzing expression of gene'
[patent_app_type] => utility
[patent_app_number] => 12/583348
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9730
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12583348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/583348 | Method of analyzing expression of gene | Aug 17, 2009 | Abandoned |
Array
(
[id] => 6303741
[patent_doc_number] => 20100162418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'RECOMBINANT PROTEIN S COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/540501
[patent_app_country] => US
[patent_app_date] => 2009-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30613
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20100162418.pdf
[firstpage_image] =>[orig_patent_app_number] => 12540501
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/540501 | Recombinant protein S composition | Aug 12, 2009 | Issued |
Array
(
[id] => 8554990
[patent_doc_number] => 08329462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Methods and compositions relating to improved lentiviral vectors and their applications'
[patent_app_type] => utility
[patent_app_number] => 12/537789
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 25154
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12537789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537789 | Methods and compositions relating to improved lentiviral vectors and their applications | Aug 6, 2009 | Issued |
Array
(
[id] => 6214506
[patent_doc_number] => 20110136896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'VARIANT HCMV PP65, IE1, AND IE2 POLYNUCLEOTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/056899
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22490
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136896.pdf
[firstpage_image] =>[orig_patent_app_number] => 13056899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056899 | VARIANT HCMV PP65, IE1, AND IE2 POLYNUCLEOTIDES AND USES THEREOF | Jul 27, 2009 | Abandoned |
Array
(
[id] => 6374928
[patent_doc_number] => 20100081201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Olig1 mini-promoters'
[patent_app_type] => utility
[patent_app_number] => 12/460347
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10584
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081201.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460347
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460347 | Olig1 mini-promoters | Jul 16, 2009 | Issued |
Array
(
[id] => 4530449
[patent_doc_number] => 07923545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-12
[patent_title] => 'Caterpiller gene family'
[patent_app_type] => utility
[patent_app_number] => 12/491487
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 117
[patent_no_of_words] => 42259
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/923/07923545.pdf
[firstpage_image] =>[orig_patent_app_number] => 12491487
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/491487 | Caterpiller gene family | Jun 24, 2009 | Issued |
Array
(
[id] => 5458783
[patent_doc_number] => 20090258935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'HYBRID ADENO-RETROVIRAL VECTOR FOR THE TRANSFECTION OF CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/488464
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21777
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488464 | HYBRID ADENO-RETROVIRAL VECTOR FOR THE TRANSFECTION OF CELLS | Jun 18, 2009 | Abandoned |
Array
(
[id] => 6080296
[patent_doc_number] => 20110142918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'ANTI-ANGIOGENIC COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/997493
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6674
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142918.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997493 | ANTI-ANGIOGENIC COMPOSITIONS AND THERAPEUTIC APPLICATIONS THEREOF | Jun 9, 2009 | Abandoned |
Array
(
[id] => 8328461
[patent_doc_number] => 08236557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Hybrid-AAV vectors to deliver large gene expression cassette'
[patent_app_type] => utility
[patent_app_number] => 12/473651
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 18031
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12473651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473651 | Hybrid-AAV vectors to deliver large gene expression cassette | May 27, 2009 | Issued |
Array
(
[id] => 6102717
[patent_doc_number] => 20110166210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'IMPROVED EXPRESSION OF IL-12 FAMILY HETERODIMERS'
[patent_app_type] => utility
[patent_app_number] => 12/992077
[patent_app_country] => US
[patent_app_date] => 2009-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18699
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166210.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992077
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992077 | Expression of IL-12 family heterodimers | May 10, 2009 | Issued |
Array
(
[id] => 6375847
[patent_doc_number] => 20100076061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'REPEATED ADMINISTRATION OF LENTIVIRAL VECTORS TO RESPIRATORY CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/433659
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11908
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076061.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433659 | REPEATED ADMINISTRATION OF LENTIVIRAL VECTORS TO RESPIRATORY CELLS | Apr 29, 2009 | Abandoned |
Array
(
[id] => 6001805
[patent_doc_number] => 20110117644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'DR5 gene promoter and SIAH-1 gene promoter'
[patent_app_type] => utility
[patent_app_number] => 12/385863
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12322
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117644.pdf
[firstpage_image] =>[orig_patent_app_number] => 12385863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385863 | DR5 gene promoter and SIAH-1 gene promoter | Apr 21, 2009 | Issued |
Array
(
[id] => 5954513
[patent_doc_number] => 20110034546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)'
[patent_app_type] => utility
[patent_app_number] => 12/936659
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9980
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12936659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936659 | Methods to produce rod-derived cone viability factor (RdCVF) | Apr 14, 2009 | Issued |
Array
(
[id] => 5495872
[patent_doc_number] => 20090263900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Linear donor constructs for targeted integration'
[patent_app_type] => utility
[patent_app_number] => 12/386059
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19624
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263900.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386059
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386059 | Linear donor constructs for targeted integration | Apr 12, 2009 | Abandoned |
Array
(
[id] => 8738072
[patent_doc_number] => 08409842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'Recombinant adeno-associated virus production'
[patent_app_type] => utility
[patent_app_number] => 12/406786
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6963
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12406786
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/406786 | Recombinant adeno-associated virus production | Mar 17, 2009 | Issued |
Array
(
[id] => 6006701
[patent_doc_number] => 20110119780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'SCREENING FOR NON-GENOTOXIC CARCINOGENS'
[patent_app_type] => utility
[patent_app_number] => 12/920717
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 20308
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20110119780.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920717
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920717 | SCREENING FOR NON-GENOTOXIC CARCINOGENS | Mar 8, 2009 | Abandoned |